Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Scientists demonstrate the existence of grid-like activity in the human brain

Scientists demonstrate the existence of grid-like activity in the human brain

Studies demonstrate effect of Ketogenic Diet on cognitive health in animals

Studies demonstrate effect of Ketogenic Diet on cognitive health in animals

Findings offer new insight into early changes that occur during AD pathology

Findings offer new insight into early changes that occur during AD pathology

Dementia and guns: When should doctors broach the topic?

Dementia and guns: When should doctors broach the topic?

Antidepressants can be used to treat Alzheimer’s disease

Antidepressants can be used to treat Alzheimer’s disease

Neuroscientists unravel how two different types of brain plasticity work on synapses

Neuroscientists unravel how two different types of brain plasticity work on synapses

Insilico to present advances in artificial intelligence at the Healthcare Innovation Summit Africa 2018

Insilico to present advances in artificial intelligence at the Healthcare Innovation Summit Africa 2018

New transgenic mouse model sheds light on biological causes of Parkinson's disease

New transgenic mouse model sheds light on biological causes of Parkinson's disease

Exposure to magnetite particles is unlikely to contribute to Alzheimer’s disease

Exposure to magnetite particles is unlikely to contribute to Alzheimer’s disease

Top journal publishes special issue on deep learning for drug discovery and biomarker development

Top journal publishes special issue on deep learning for drug discovery and biomarker development

Personalized goal setting to improve dementia care

Personalized goal setting to improve dementia care

Columbia scientist and collaborators receive $11.3 million to find new targets against brain disease

Columbia scientist and collaborators receive $11.3 million to find new targets against brain disease

Antiepileptic drug use associated with elevated stroke risk in Alzheimer’s patients

Antiepileptic drug use associated with elevated stroke risk in Alzheimer’s patients

New AUC published for lumbar puncture and spinal fluid analysis in Alzheimer's diagnosis

New AUC published for lumbar puncture and spinal fluid analysis in Alzheimer's diagnosis

Memory 'brainwaves' are identical in sleep and wakefulness

Memory 'brainwaves' are identical in sleep and wakefulness

Scientists identify new biomarker for Alzheimer's disease of sporadic origin

Scientists identify new biomarker for Alzheimer's disease of sporadic origin

PolyU develops multi-function nighttime monitoring system for elderly with dementia

PolyU develops multi-function nighttime monitoring system for elderly with dementia

Study suggests novel approach to treating adults with autism spectrum disorder

Study suggests novel approach to treating adults with autism spectrum disorder

Researchers show possibility to restore insulin cell function in type 2 diabetes

Researchers show possibility to restore insulin cell function in type 2 diabetes

Dementia prevention trial participants are motivated by altruism, study suggests

Dementia prevention trial participants are motivated by altruism, study suggests

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.